An Oral Ketamine Drug for Depression — Minus the Trip?

Published Date: 16 Jul 2026

A novel oral ketamine drug shows a signal for reducing depressive symptoms with minimal dissociative effects.

Read Full News

Todays Updates


Fast Symptom Relief in Ulcerative Colitis: Which Rx Wins?


Upadacitinib and infliximab offer rapid relief from symptoms in biologic-naive patients with moderate-to-severe ulcerative colitis.

Europe’s AI Reality: Practice Outpaces Policy and Reviews


Clinicians and patients are already relying on AI, while hospitals are still building the oversight to keep up.

Info on Risk for Prostate Cancer Spurs Decision-Making


Men who receive personalized estimates of the likelihood of raised prostate-specific antigen levels are more likely to decide to get screening than those who receive general information on pros and cons.

Cognitive Benefit of Healthy Living Confirmed: LatAm-FINGERS


A culturally tailored lifestyle program improves cognition significantly more than standard health advice among older adults at risk for dementia across Latin America.

Health Issues Tied to Behaviours in Intellectual Disability


People with intellectual disabilities who have physical health problems or sensory impairments face a higher risk for challenging behaviours.

Rimegepant Effective in Treatment-Resistant Migraine


Rimegepant is safe and effective in patients with migraine not responding to multiple prior preventive therapies, a real-world study shows.

Treatment Before Tests Makes No Difference for Kidney Stones


Preventive therapy given immediately or guided by urine tests yields similar results for incidence of calcium stones at 8 weeks in patients with recurrent kidney stones.

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Early Results for Anorexia Nervosa with Psilocybin.

2.

Vaccine shows promise for pancreatic cancer, study finds

3.

Mindfulness-based interventions are advised by cancer organizations to treat patients' anxiety and depression.

4.

Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.

5.

Rural-urban disparities seen in cervical cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot